Navigation Links
Mobidiag Releases First Microarray Based Rapid Test for Herpesvirus Identification
Date:3/12/2008

Prove-it Herpes Offers Considerable Cost Savings for Healthcare Industry by

Identifying Eight Herpesviruses Simultaneously

HELSINKI, Finland, March 12 /PRNewswire/ -- The Finland-based biotechnology company Mobidiag today announced the new Prove-it(TM) Herpes test for the fast and reliable identification of herpesviruses. The microarray-based test takes less than three hours to complete and enables simultaneous identification of eight different human herpesviruses. Herpesviruses cause life-threatening central nervous system infections (CNSI), and rapid diagnosis improves likelihood of recovery. The new test is initially intended for research purposes, and Mobidiag plans to acquire European approval for use in clinical diagnostics later this year.

"Market potential for the product is enormous. In Europe alone, over 100 million euros are spent annually on herpesvirus diagnostics. We believe that Prove-it(TM) Herpes will gain a considerable slice of that market," says Jaakko Pellosniemi, CEO of Mobidiag. "What makes Prove-it(TM) Herpes unique is that it combines different technologies and integrates them into a single easy-to-use and capable product," Pellosniemi continues.

In addition to illnesses such as labial herpes, chickenpox and roseola, herpesviruses can also cause serious central nervous system infections such as encephalitis. Without appropriate treatment, mortality rate from these infections can be as high as 50%. The sooner the pathogen is detected, the higher the likelihood of recovery. However, virus detection may be slow with current methods, and in severe suspected virus infection cases, medication is often started merely as a precaution. There are roughly four million of these suspected cases annually in the Industrial World, making testing and treating potential infections very expensive.

The Mobidiag test can detect and identify the viruses many times faster than conventional methods. Appropriate antiviral treatment can be administered sooner, and the level of potential permanent damage to the patient is decreased. Additionally, Mobidiag's test reveals multi-infections caused by several herpesviruses. The detection is also exceptionally sensitive to low viral loads, which are typical in the early stages of a central nervous system infection.

"We believe that in the future, microarray-based tests will quickly become common in diagnostics due to their simplicity, speed, and reliability. A clinician can instantly check hundreds of viral and bacterial-based illnesses, offering a huge saving potential for the healthcare industry. Mobidiag will play a vital role in this development," says Pellosniemi.

Founded in 2001, Mobidiag develops rapid diagnostic tests for hospital laboratories. The Prove-it(TM) Herpes test is developed in co-operation with Hospital Districts of Helsinki and Uusimaa and the University of Helsinki.

Additional information:

Mobidiag Ltd is a Finnish biotechnology company developing, producing and marketing rapid diagnostic tests to hospital laboratories. The company focuses on detection of serious infections with DNA-tests. More information on http://www.mobidiag.com

- Press photos from http://www.mobidiag.com/media/images

- CEO Jaakko Pellosniemi, Mobidiag Ltd, tel. +358-40-501-1004

- Press contact, Ville Lehtovirta, +358-50-346-6946, ville.lehtovirta@conexio.fi


'/>"/>
SOURCE Mobidiag Ltd
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Beckman Coulter Releases the High-Volume UniCel(R) DxC 880i Integrated Work Cell
2. BioCrossroads Launches www.biocrossroadslinx.com and Releases Report on Biopharma Discovery and Development Contract Services
3. MIGENIX releases CEO message #22
4. National Nanotechnology Initiative releases its fiscal year 2009 budget and highlights
5. CellCyte Genetics Corp. Continues to Move Its Technology Forward in Light of Plaintiff Law Firm Press Releases
6. Intrasphere Technologies Releases PharmaCM Submissions Management and Authoring Module Powered by Microsoft Office SharePoint Server 2007
7. Techne Corporation Releases Unaudited Second Quarter Results for Fiscal Year 2008
8. Clontech Laboratories, Inc. Releases the ProteoTuner(TM) Systems
9. BioTrends Releases Fourth Annual Nephrology TreatmentTrends Publication Highlighting Market Trends for Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism
10. CellCyte Genetics Corp. Responds to Plaintiff Law Firm Press Releases
11. Seven Summits Research Releases Alerts on XOM, MER, DRYS, CSC, and PDLI
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... Mass. , June 23, 2016   ... development of novel compounds designed to target cancer ... napabucasin, has been granted Orphan Drug Designation from ... the treatment of gastric cancer, including gastroesophageal junction ... stemness inhibitor designed to inhibit cancer stemness pathways ...
(Date:6/23/2016)... -- Houston Methodist Willowbrook Hospital has signed a ... serve as their official health care provider. As ... provide sponsorship support, athletic training services, and most ... athletes and families. "We are excited ... to bring Houston Methodist quality services and programs ...
(Date:6/23/2016)... YORK , June, 23, 2016  The Biodesign ... to envision new ways to harness living systems and ... Modern Art (MoMA) in New York City ... than 130 participating students, showcased projects at MoMA,s Celeste ... Paola Antonelli , MoMA,s senior curator of architecture ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... STACS DNA ... Technical Leader at the Arkansas State Crime Laboratory, has joined STACS DNA as a ... STACS DNA team,” said Jocelyn Tremblay, President and COO of STACS DNA. “In further ...
Breaking Biology Technology:
(Date:6/21/2016)... , June 21, 2016 NuData Security announced ... new role of principal product architect and that ... director of customer development. Both will report directly ... officer. The moves reflect NuData,s strategic growth in ... to high customer demand and customer focus values. ...
(Date:6/15/2016)... , June 15, 2016 ... market report titled "Gesture Recognition Market by Application Market - Global ... 2016 - 2024". According to the report, the  global ... billion in 2015 and is estimated to grow ... 48.56 billion by 2024.  Increasing application ...
(Date:6/7/2016)... TORONTO , June 7, 2016  Syngrafii ... begun a business relationship that includes integrating Syngrafii,s ... pilot branch project. This collaboration will result in ... for the credit union, while maintaining existing document ... http://photos.prnewswire.com/prnh/20160606/375871LOGO ...
Breaking Biology News(10 mins):